JP2024527557A5 - - Google Patents
Info
- Publication number
- JP2024527557A5 JP2024527557A5 JP2023580778A JP2023580778A JP2024527557A5 JP 2024527557 A5 JP2024527557 A5 JP 2024527557A5 JP 2023580778 A JP2023580778 A JP 2023580778A JP 2023580778 A JP2023580778 A JP 2023580778A JP 2024527557 A5 JP2024527557 A5 JP 2024527557A5
- Authority
- JP
- Japan
- Prior art keywords
- immune effector
- effector cells
- seq
- binding polypeptide
- antigen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110749481.6 | 2021-07-01 | ||
| CN202110749481 | 2021-07-01 | ||
| PCT/CN2022/103070 WO2023274384A1 (zh) | 2021-07-01 | 2022-06-30 | 靶向b7h3的抗原结合多肽及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527557A JP2024527557A (ja) | 2024-07-25 |
| JP2024527557A5 true JP2024527557A5 (https=) | 2025-07-07 |
Family
ID=84690474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580778A Pending JP2024527557A (ja) | 2021-07-01 | 2022-06-30 | Ｂ７ｈ３を標的とする抗原結合ポリペプチド及びその応用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12133890B2 (https=) |
| EP (1) | EP4365203A4 (https=) |
| JP (1) | JP2024527557A (https=) |
| KR (1) | KR20240027117A (https=) |
| CN (1) | CN115916833B (https=) |
| AU (1) | AU2022301099A1 (https=) |
| CA (1) | CA3224476A1 (https=) |
| MX (1) | MX2023015153A (https=) |
| WO (1) | WO2023274384A1 (https=) |
| ZA (1) | ZA202401043B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117986362A (zh) * | 2022-11-04 | 2024-05-07 | 茂行制药(苏州)有限公司 | 靶向b7h3的通用型car-t细胞及其制备方法和应用 |
| EP4680643A1 (en) * | 2023-03-17 | 2026-01-21 | Beone Medicines I GmbH | Anti-b7h3 antibodies and methods of use |
| CN119486745A (zh) * | 2023-05-24 | 2025-02-18 | 茂行制药(苏州)有限公司 | 用于靶向b7h3的同种异体嵌合抗原受体t细胞的给药的方法和组合物 |
| CN118829656B (zh) * | 2023-12-01 | 2026-04-24 | 苏州智核生物医药科技有限公司 | B7h3结合多肽及其用途 |
| CN117924518B (zh) * | 2024-01-05 | 2025-08-22 | 苏州艾凯利元生物科技有限公司 | 用于nk细胞的嵌合抗原受体及工程化的nk细胞 |
| WO2025219520A1 (en) * | 2024-04-18 | 2025-10-23 | Match Medicines Gmbh | MODIFIED HUMAN T CELL WITH A REDUCED HLA-Ia REPERTOIRE AND METHOD OF PRODUCTION |
| WO2025255308A1 (en) * | 2024-06-07 | 2025-12-11 | Intellia Therapeutics, Inc. | Cd8 co-receptor chimeric polypeptides in tcr cell therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE513854T1 (de) * | 2000-12-13 | 2011-07-15 | Bac Ip B V | Proteinraster aus variablen domänen der schweren immunoglobulinkette von kamelen |
| EP2650311A3 (en) * | 2007-11-27 | 2014-06-04 | Ablynx N.V. | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| KR101763499B1 (ko) | 2012-11-07 | 2017-07-31 | 화이자 인코포레이티드 | 항-il-13 수용체 알파 2 항체 및 항체-약물 접합체 |
| US20190136230A1 (en) * | 2016-05-06 | 2019-05-09 | Juno Therapeutics, Inc. | Genetically engineered cells and methods of making the same |
| EP4029943A1 (en) * | 2017-05-08 | 2022-07-20 | Precision Biosciences, Inc. | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof |
| KR20200075851A (ko) * | 2017-10-19 | 2020-06-26 | 셀렉티스 | 개선된 면역 세포들 치료를 위한 nk 억제제들의 타겟인 유전자 통합 |
| WO2020010239A1 (en) * | 2018-07-06 | 2020-01-09 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric antigen receptor polypeptides and methods of using same |
| CN113166261A (zh) * | 2018-10-11 | 2021-07-23 | 印希比股份有限公司 | B7h3单域抗体及其治疗性组合物 |
| CN112390892B (zh) * | 2019-08-14 | 2024-01-12 | 博源润生医药（杭州）有限公司 | 一种嵌合抗原受体以及表达该嵌抗原受体的免疫效应细胞 |
| JP7748935B2 (ja) | 2019-08-27 | 2025-10-03 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ＩＬ１３Ｒα２陽性ヒト腫瘍およびイヌ腫瘍を処置するための合成ＣＡＲ |
| CA3156761A1 (en) * | 2019-10-22 | 2021-04-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | High affinity nanobodies targeting b7h3 (cd276) for treating multiple solid tumors |
| AU2020418199B2 (en) * | 2020-01-02 | 2024-06-13 | Ningbo T-Maximum Biopharmaceuticals Co., Ltd. | Modified immune effector cell and preparation method therefor |
-
2022
- 2022-06-30 EP EP22832196.4A patent/EP4365203A4/en active Pending
- 2022-06-30 AU AU2022301099A patent/AU2022301099A1/en active Pending
- 2022-06-30 US US18/575,650 patent/US12133890B2/en active Active
- 2022-06-30 KR KR1020247003777A patent/KR20240027117A/ko active Pending
- 2022-06-30 WO PCT/CN2022/103070 patent/WO2023274384A1/zh not_active Ceased
- 2022-06-30 CN CN202280004519.XA patent/CN115916833B/zh active Active
- 2022-06-30 JP JP2023580778A patent/JP2024527557A/ja active Pending
- 2022-06-30 MX MX2023015153A patent/MX2023015153A/es unknown
- 2022-06-30 CA CA3224476A patent/CA3224476A1/en active Pending
-
2024
- 2024-01-31 ZA ZA2024/01043A patent/ZA202401043B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527557A5 (https=) | ||
| Azuma | Co-signal molecules in T-cell activation: historical overview and perspective | |
| JP2025032091A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| JP2024534847A5 (https=) | ||
| JP2020533958A5 (https=) | ||
| JP2022534680A5 (https=) | ||
| JP2018527014A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| JP2022040287A5 (https=) | ||
| JP2019523301A5 (https=) | ||
| IL317912A (en) | A combined chimeric antigen receptor targeting CD19 and CD20 and its applications | |
| JP2025038057A5 (https=) | ||
| JP2017524367A5 (https=) | ||
| JP2021524264A5 (https=) | ||
| JP2018535701A5 (https=) | ||
| JP2021500881A5 (https=) | ||
| CN115916833A (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| JP2022520455A5 (https=) | ||
| JP2023519346A5 (https=) | ||
| JP2023553390A5 (https=) | ||
| JP2022513372A5 (https=) | ||
| KR20230066007A (ko) | 신규한 보조자극 도메인을 포함하는 키메라 항원 수용체 및 이의 용도 | |
| US20230051885A1 (en) | Systems and Methods for Producing Efficacious Regulatory T Cells | |
| JP2022546577A5 (https=) |